Navigation Links
Testosterone Cream Ineffective in Enhancing Libido in Female Cancer Survivors

The much talked about testosterone cream for enhancing sexual desire in female cancer survivors did not prove very effective, a new study conducted by Mayo clinic has shown.

A low sex drive is common in women cancer survivors. As an extension to a previous study which pointed a link between androgen therapy and increased sex drive in women with sufficient estrogen levels, this new study was conducted on 150 post menopausal cancer survivors.

The women were divided into two groups. One group got a testosterone cream and the other received a placebo for four weeks. For the ensuing four weeks, treatment was interchanged between the groups.

The groups had to answer a questionnaire in the beginning of the program and subsequently at four and eight weeks regarding their desire for sex. The finding revealed, there was no difference in libido between the two groups. Instead both groups showed a marginal increase in libido, portraying a placebo effect, rather than the effect of the testosterone cream.

Explaining that the ineffectiveness of the testosterone cream could be attributed to low estrogen levels among the women who took part in the study, researchers said, "If providing supplemental estrogen to women who are postmenopausal is required to obtain a benefit from androgen therapy, then it does not appear that androgen supplementation would be a viable option for women who must avoid (estrogen) replacement."


'"/>




Page: 1

Related medicine news :

1. Testosterone Replacement Therapy Safe If Monitored Appropriately
2. Low Testosterone Levels the Cause Of Depression In Men
3. The Use Of Testosterone Replacement Therapy Questioned
4. Depression In Men Could Be To Low Testosterone Levels
5. Testosterone patch for women Rejected For safety Reasons
6. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
7. Testosterone Therapy can improve sexual function in postmenopausal women
8. Fatherhood Found To Tame Men by Reducing Testosterone Levels
9. Testosterone levels could serve as a marker for determining risk of SIDS
10. Males Lifespan Shortened By Elevated Levels Of Testosterone
11. Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone Therapy
Post Your Comments:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...n revive its human organ donation programme in a b...elopments.// Health and Child Welfare Deputy Min... on resuscitating the programme. Because of its in...raft strong legislative laws to guard it from abus...
...US claim to have identified an alternative diet-ba...crease the growth of brain tumours. // The diet id...eyfried and other researchers is KetoCal, a commer...ydrate diet designed to treat epilepsy in children...
...ent is at loggerheads with the pharmaceutical indu...s for generic medicines. // While Thailand argues ...able to its citizens, drug companies maintain that... law and discourages foreign investment. "We were...
...on therapy may aggravate heart disease in patients...ers at Dana-Farber Cancer Institute. // ADT is one.... The study results were based on data from CaPSU...men with prostate cancer. Although the findings ne...
Other Medicine News:Health News:Diet-based Method to Treat Brain Cancer 2Health News:Drug Companies Hit Out at Thai Generic Drug Scheme 2Health News:Benefits of ADT Against Risk of Heart Ailments 2
(Date:10/7/2008)...Results of FLEXX Trial Presented at the Osteoarthr...ongress, PARSIPPANY, N.J., Oct. 7 /-...esults from the FLEXX Trial of Osteoarthritis of t...ronate), a highly pure,non-avian high molecular we...A), is superior to intra-articular saline (IA-sali...
(Date:10/7/2008)...FORT COLLINS, Colo., Oct. 7 /- A stud...ning embryonic stem cell self-renewal,reported th...m (recombinant,human serum albumin) was an effecti...culture., The article entitled, "The ground state...hat researchers used Cellastim as a recombinant,al...
(Date:10/7/2008)...Patient, Prospective Randomized Placebo-Controlled...ficant Improved Overall Survival., MOUNTAIN VIEW,...erapeutics has now evaluated the mature Phase II d...andidate PROSTVAC(TM) that had been,obtained as pa...tional,Cancer Institute (NCI) in the US., The res...
(Date:10/6/2008)...TOKYO and CHIPPENHAM, England, October 7 /PRNewswi... TSE Mothers Index: 4565) and Vectura,Group plc ("... II studies,evaluating the efficacy, safety and to...ess of the European Respiratory Society (ERS) in B...copyrronium bromide), a novel,inhaled long-acting ...
Breaking Medicine Technology:Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Jazz Pharmaceuticals Announces 2426 0 Million Registered Direct Offering 6576 1Jazz Pharmaceuticals Announces 2426 0 Million Registered Direct Offering 6576 2Jazz Pharmaceuticals Announces 2426 0 Million Registered Direct Offering 6576 3Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery 2645 1Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery 2645 2Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery 2645 3Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery 2645 4BioWa and Medarex Announce License of BioWas COMPLEGENT 28TM 29 Technology 6573 1BioWa and Medarex Announce License of BioWas COMPLEGENT 28TM 29 Technology 6573 2BioWa and Medarex Announce License of BioWas COMPLEGENT 28TM 29 Technology 6573 3BioWa and Medarex Announce License of BioWas COMPLEGENT 28TM 29 Technology 6573 4Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2642 1Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2642 2Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2642 3Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2642 4Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2642 5
... - Peregrine,s Selective Anti-VEGF Antibodies In...In a Preclinical Cancer Model -, , - Peregrine,s A... Could , Potentially Have Advantages over Non-Sele...ta Presented on a Fully Human,Antibody Support , A...nical Trials,- , LOS ANGELES and TUSTIN, Calif., A...
...NTSVILLE, Ala., April 16, 2007 /PRNewswire/ -- Exp...tion of a Phase I,clinical study evaluating the Co...conducted at The University of Alabama at,Birmingh...ary,efficacy, and biological activity of the EGEN-...ial ovarian cancer. The product,utilizing the Com...
Other Medicine Technology:Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 2Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 3Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 4Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 5Expression Genetics, Inc. Announces Successful Completion of Phase,I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer 2Expression Genetics, Inc. Announces Successful Completion of Phase,I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer 3Expression Genetics, Inc. Announces Successful Completion of Phase,I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer 4
Angled 60 degree blades 5.5 mm.
Accurately tests for Nystagmus when rotated at 8-10 rpm. Drums are 10" high by 8" diameter. Light weight drum of professional quality with ball bearings for effortless spin mechanism. For use 24 to 3
Eschenbach's new 2636 series of stand magnifiers delivers the benefits of high power and a large fields of view. Using a unique doublet lens design, the 2636 offers the highest power recatngular lens
This Illuminated Stand Magnifier offers versatility across a number of different applications. Both the lens and the light are adjustable. Simply tilt the lens and small hand held objects can be work
Medicine Products: